nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2D6—Parkinson's disease	0.925	1	CbGaD
Bicalutamide—Enzalutamide—CYP2D6—Parkinson's disease	0.00429	0.583	CrCbGaD
Bicalutamide—Enzalutamide—ABCB1—Parkinson's disease	0.00306	0.417	CrCbGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000363	0.00535	CbGpPWpGaD
Bicalutamide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000359	0.00528	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.000342	0.00503	CbGpPWpGaD
Bicalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000342	0.00503	CbGpPWpGaD
Bicalutamide—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00034	0.005	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000334	0.00492	CbGpPWpGaD
Bicalutamide—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000333	0.00491	CbGpPWpGaD
Bicalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000333	0.0049	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000331	0.00488	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000331	0.00487	CbGpPWpGaD
Bicalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000329	0.00484	CbGpPWpGaD
Bicalutamide—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000313	0.0046	CbGpPWpGaD
Bicalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000305	0.00448	CbGpPWpGaD
Bicalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000304	0.00447	CbGpPWpGaD
Bicalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000301	0.00443	CbGpPWpGaD
Bicalutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0003	0.00441	CbGpPWpGaD
Bicalutamide—AR—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.000294	0.00432	CbGpPWpGaD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000289	0.00425	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.000281	0.00414	CbGpPWpGaD
Bicalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00028	0.00412	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00028	0.00411	CbGpPWpGaD
Bicalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000278	0.00409	CbGpPWpGaD
Bicalutamide—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000277	0.00407	CbGpPWpGaD
Bicalutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000274	0.00404	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00027	0.00398	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00027	0.00397	CbGpPWpGaD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000256	0.00377	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000247	0.00364	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000246	0.00362	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000239	0.00352	CbGpPWpGaD
Bicalutamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000236	0.00348	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PRKRA—Parkinson's disease	0.000234	0.00344	CbGpPWpGaD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000233	0.00343	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000233	0.00343	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000229	0.00338	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000228	0.00335	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000227	0.00334	CbGpPWpGaD
Bicalutamide—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000227	0.00334	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000226	0.00332	CbGpPWpGaD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000225	0.00332	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000225	0.00332	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000219	0.00322	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.000217	0.00319	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000214	0.00314	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000204	0.003	CbGpPWpGaD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000203	0.00299	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.0002	0.00295	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000199	0.00293	CbGpPWpGaD
Bicalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000198	0.00291	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000197	0.00291	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000196	0.00289	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000195	0.00287	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000193	0.00284	CbGpPWpGaD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000187	0.00275	CbGpPWpGaD
Bicalutamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000185	0.00273	CbGpPWpGaD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000183	0.0027	CbGpPWpGaD
Bicalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000181	0.00266	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000178	0.00261	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000176	0.00259	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—TAF1—Parkinson's disease	0.000165	0.00242	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NR4A2—Parkinson's disease	0.000165	0.00242	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000162	0.00239	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000154	0.00227	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000149	0.00219	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000143	0.00211	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000141	0.00208	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000138	0.00204	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000135	0.00199	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000135	0.00198	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—RPL6—Parkinson's disease	0.000132	0.00194	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000131	0.00193	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000131	0.00193	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00013	0.00192	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000129	0.0019	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000129	0.0019	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000128	0.00189	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000122	0.0018	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000121	0.00178	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00012	0.00177	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.00012	0.00176	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000119	0.00175	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000118	0.00174	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000116	0.00171	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000115	0.00169	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000109	0.00161	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000109	0.0016	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000108	0.00159	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000108	0.00159	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000107	0.00158	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000107	0.00157	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000105	0.00155	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.0001	0.00147	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—RPL23A—Parkinson's disease	9.97e-05	0.00147	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—RPL14—Parkinson's disease	9.97e-05	0.00147	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	9.95e-05	0.00146	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	9.94e-05	0.00146	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	9.93e-05	0.00146	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—COMT—Parkinson's disease	9.91e-05	0.00146	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	9.87e-05	0.00145	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	9.86e-05	0.00145	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	9.84e-05	0.00145	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	9.82e-05	0.00144	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	9.81e-05	0.00144	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	9.8e-05	0.00144	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	9.78e-05	0.00144	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	9.73e-05	0.00143	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—RPS8—Parkinson's disease	9.3e-05	0.00137	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	9.15e-05	0.00135	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	9.07e-05	0.00133	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	9.02e-05	0.00133	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	8.94e-05	0.00132	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	8.63e-05	0.00127	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.51e-05	0.00125	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	8.33e-05	0.00123	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.91e-05	0.00116	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	7.89e-05	0.00116	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.78e-05	0.00115	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.49e-05	0.0011	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—HSPA8—Parkinson's disease	7.45e-05	0.0011	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CTGF—Parkinson's disease	7.42e-05	0.00109	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ND3—Parkinson's disease	7.05e-05	0.00104	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MCCC1—Parkinson's disease	7.05e-05	0.00104	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	6.83e-05	0.001	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—HSPA1A—Parkinson's disease	6.78e-05	0.000998	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—OMD—Parkinson's disease	6.63e-05	0.000976	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TALDO1—Parkinson's disease	6.63e-05	0.000976	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.54e-05	0.000962	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.51e-05	0.000958	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.49e-05	0.000956	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.48e-05	0.000954	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ND3—Parkinson's disease	6.48e-05	0.000954	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.45e-05	0.000949	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ND3—Parkinson's disease	6.43e-05	0.000946	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MCCC1—Parkinson's disease	6.43e-05	0.000946	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6.42e-05	0.000945	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	6.28e-05	0.000925	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—OMD—Parkinson's disease	6.1e-05	0.000897	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.1e-05	0.000897	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—OMD—Parkinson's disease	6.04e-05	0.00089	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TALDO1—Parkinson's disease	6.04e-05	0.00089	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GCH1—Parkinson's disease	5.99e-05	0.000882	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.98e-05	0.00088	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.9e-05	0.000868	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	5.78e-05	0.000851	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	5.73e-05	0.000843	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.51e-05	0.000812	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GCH1—Parkinson's disease	5.47e-05	0.000805	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.41e-05	0.000796	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—DBH—Parkinson's disease	5.34e-05	0.000786	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GBA—Parkinson's disease	5.34e-05	0.000786	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—FBP1—Parkinson's disease	5.34e-05	0.000786	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.93e-05	0.000726	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GBA—Parkinson's disease	4.91e-05	0.000723	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—DBH—Parkinson's disease	4.91e-05	0.000723	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.91e-05	0.000723	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—FBP1—Parkinson's disease	4.87e-05	0.000717	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—DBH—Parkinson's disease	4.87e-05	0.000717	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GBA—Parkinson's disease	4.87e-05	0.000717	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ND3—Parkinson's disease	4.24e-05	0.000624	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.24e-05	0.000624	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.99e-05	0.000587	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—OMD—Parkinson's disease	3.99e-05	0.000587	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—DDC—Parkinson's disease	3.92e-05	0.000577	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.78e-05	0.000556	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA4—Parkinson's disease	3.7e-05	0.000545	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.66e-05	0.000538	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—DDC—Parkinson's disease	3.61e-05	0.000531	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.6e-05	0.000531	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—DDC—Parkinson's disease	3.58e-05	0.000526	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.41e-05	0.000501	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA4—Parkinson's disease	3.38e-05	0.000497	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.33e-05	0.000491	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.33e-05	0.000491	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.3e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.21e-05	0.000473	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—DBH—Parkinson's disease	3.21e-05	0.000473	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GBA—Parkinson's disease	3.21e-05	0.000473	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.14e-05	0.000462	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.07e-05	0.000451	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.04e-05	0.000448	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.04e-05	0.000447	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.01e-05	0.000443	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.86e-05	0.000422	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.45e-05	0.000361	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.41e-05	0.000354	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—DDC—Parkinson's disease	2.36e-05	0.000347	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.24e-05	0.00033	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.24e-05	0.000329	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.23e-05	0.000328	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.22e-05	0.000327	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.21e-05	0.000326	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.2e-05	0.000323	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TH—Parkinson's disease	2.19e-05	0.000322	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.1e-05	0.000309	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.06e-05	0.000304	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.05e-05	0.000301	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.04e-05	0.0003	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.02e-05	0.000298	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TH—Parkinson's disease	2.01e-05	0.000296	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.01e-05	0.000295	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TH—Parkinson's disease	1.99e-05	0.000293	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.98e-05	0.000292	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.93e-05	0.000284	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.91e-05	0.000282	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—COMT—Parkinson's disease	1.86e-05	0.000274	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.85e-05	0.000272	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.85e-05	0.000272	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.82e-05	0.000269	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.75e-05	0.000258	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—COMT—Parkinson's disease	1.71e-05	0.000252	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.7e-05	0.000251	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.7e-05	0.00025	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.7e-05	0.00025	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—COMT—Parkinson's disease	1.7e-05	0.00025	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.69e-05	0.000248	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.68e-05	0.000248	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.68e-05	0.000247	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.66e-05	0.000245	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.63e-05	0.00024	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.61e-05	0.000237	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.6e-05	0.000235	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.56e-05	0.00023	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.55e-05	0.000228	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.5e-05	0.000221	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.5e-05	0.00022	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.48e-05	0.000219	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.48e-05	0.000217	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.45e-05	0.000213	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOE—Parkinson's disease	1.4e-05	0.000206	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.38e-05	0.000203	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.37e-05	0.000202	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.35e-05	0.000199	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.33e-05	0.000196	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TH—Parkinson's disease	1.31e-05	0.000194	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOE—Parkinson's disease	1.29e-05	0.000189	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOE—Parkinson's disease	1.28e-05	0.000188	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.26e-05	0.000186	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—INS—Parkinson's disease	1.2e-05	0.000176	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—COMT—Parkinson's disease	1.12e-05	0.000165	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.11e-05	0.000164	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.11e-05	0.000163	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—INS—Parkinson's disease	1.1e-05	0.000162	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.1e-05	0.000162	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—INS—Parkinson's disease	1.09e-05	0.00016	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.05e-05	0.000155	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.02e-05	0.000151	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.79e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	9.04e-06	0.000133	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOE—Parkinson's disease	8.41e-06	0.000124	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—INS—Parkinson's disease	7.19e-06	0.000106	CbGpPWpGaD
